Effective treatment of recurrent acromegaly with a long-active somatostatin analogue (sandostatin).
Miranda
R
R
Zárate
A
A
Ruíz Velasco
G
G
D000172:Acromegaly / Q000188:drug therapy* / Q000209:etiology / Q000601:surgery; D000236:Adenoma / Q000150:complications / Q000601:surgery; D000328:Adult; D003131:Combined Modality Therapy; D003692:Delayed-Action Preparations; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007279:Injections, Subcutaneous; D008297:Male; D008875:Middle Aged; D015282:Octreotide / Q000008:administration & dosage / Q000627:therapeutic use*; D010911:Pituitary Neoplasms / Q000150:complications / Q000601:surgery
D003692:Delayed-Action Preparations; D015282:Octreotide